Related and Nonrelated Parties [Axis]
Related Party [Member]
Product and Service [Axis]
Restricted Gold [Member]
Gold [Member]
Class of Stock [Axis]
Series C 9% Convertible Preferred Stock [Member]
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Series C Preferred Stock [Member]
Series D Preferred Stock [Member]
Series E Preferred Stock [Member]
Series F Preferred Stock [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Investment, Name [Axis]
Viral Clear [Member]
BioSig AI Sciences, Inc. [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Customer [Axis]
One Customer [Member]
Geographical [Axis]
UNITED STATES
CANADA
Long-Lived Tangible Asset [Axis]
Computer Equipment [Member]
Furniture and Fixtures [Member]
Testing Demo Equipment [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Warrant [Member]
Convertible Debentures Convertible [Member]
Restricted Stock [Member]
Testing and Demo Equipment [Member]
Leasehold Improvements [Member]
Indefinite-Lived Intangible Assets [Axis]
Trade Names [Member]
Developed Technology Rights [Member]
Legal Contact [Member]
Patents [Member]
Compliance Framework [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Legal and Compliance Frame Work [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Premium Finance Agreement [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Title and Position [Axis]
Chief Executive Officer [Member]
Legal Entity [Axis]
Endicott Management Partners LLC [Member]
Investor [Member]
Purchase Agreement [Member]
Statistical Measurement [Axis]
Maximum [Member]
Underwriting Agreement [Member]
Streamex Exchange Acquisition [Member]
Third Party Consultant [Member]
Sales Agreement [Member]
Market Offering Agreement [Member]
Award Type [Axis]
Plan Name [Axis]
2023 Long-Term Incentive Plan [Member]
Statement Of Income Location Balance [Axis]
General and Administrative Expenses [Member]
Restricted Stock Units (RSUs) [Member]
Consultants [Member]
Restricted Stock Awards [Member]
Third Party Consultants And Employees [Member]
Restricted Stock Units and Restricted Stock Awards [Member]
Chief Investment Officer [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Future Vested [Member]
Key Consultant [Member]
Employees [Member]
2019 Long-Term Incentive Plan [Member]
Business Combination [Axis]
Viral Clear Pharmaceuticals Inc [Member]
BioSig AI Sciences, Inc. [Member]
Exercise Price Range [Axis]
Options Under 9.99 [Member]
Options 10.00 To 19.99 [Member]
Options 20.00 To 49.99 [Member]
Options 50.00 To 69.99 [Member]
Measurement Input Type [Axis]
Measurement Input, Share Price [Member]
Measurement Input, Price Volatility [Member]
Minimum [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Expected Dividend Rate [Member]
Measurement Input, Expected Term [Member]
Warrants At 0.3000 [Member]
Warrants At 0.9547 [Member]
Warrants At 1.7800 [Member]
Warrants At 3.3640 [Member]
Warrants At 4.0660 [Member]
Warrants At 4.4550 [Member]
Warrants At 4.6626 [Member]
Warrants At 4.9252 [Member]
Warrants At 4.9290 [Member]
Warrants At 5.1358 [Member]
Warrants At 7.1810 [Member]
Warrants At 7.5020 [Member]
Warrants At 7.9630 [Member]
Warrants At 9.0000 [Member]
Warrants At 9.5960 [Member]
Warrants At 10.0992 [Member]
Warrants At 10.2600 [Member]
Warrants At 10.4678 [Member]
Warrants At 11.3000 [Member]
Warrants At 13.2800 [Member]
Warrants At 48.0000 [Member]
Warrants At 61.6000 [Member]
Consolidated Entities [Axis]
Monetary Metals & Co. [Member]
Streamex Exchange Corporation [Member]
Share Purchase Agreement [Member]
Technology-Based Intangible Assets [Member]
Securitization Platform [Member]
Blockchain Integration [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 3 [Member]
Measurement Frequency [Axis]
Fair Value, Nonrecurring [Member]
Developed Technology [Member]
Financial Instrument [Axis]
Trade Name [Member]
Valuation Approach and Technique [Axis]
Relief from Royalty Method [Member]
Royalty Rate [Member]
Revenue Growth Rate [Member]
Discount Rate [Member]
Income Tax Rate [Member]
Tax Amortization Period [Member]
Multi Period Excess Earnings Method [Member]
Revenue Growth Rates [Member]
Contributory Assets Charge [Member]
Obsolece [Member]
Earnings Before Interest and Taxes [Member]
Cost Approach [Member]
Replacement Cost Growth Rate [Member]
Cap Ex Rates [Member]
After Tax Rate of Return [Member]
Useful Life [Member]
Valuation Technique, Discounted Cash Flow [Member]
Terminal Growth Rate [Member]
Capitalization Rate [Member]
Expense Rate [Member]
Capital Expenditure Rate [Member]
Measurement Input, Credit Spread [Member]
Measurement Input Risky Yield [Member]
Measurement Input, Discount Rate [Member]
Measurement Input, Prepayment Rate [Member]
Fair Value, Inputs, Level 1 [Member]
Restricted [Member]
Unrestricted [Member]
Brinks Bailee Agreement [Member]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Payment Arrangement, Tranche Two [Member]
Debenture Purchase Agreement [Member]
Debt Instrument [Axis]
First Closing [Member]
Second Closing [Member]
Income Tax Jurisdiction [Axis]
Domestic Tax Jurisdiction [Member]
Tax Period [Axis]
2026-2031 [Member]
State and Local Jurisdiction [Member]
Foreign Tax Jurisdiction [Member]
2032-2037 [Member]
2038 to 2045 [Member]
Segments [Axis]
Corporate Segment [Member]
Henry McPhie [Member]
Sale of Stock [Axis]
IPO [Member]
Over-Allotment Option [Member]
Empress Royalty Corp [Member]
Non Employee Director [Member]
Executive Committee [Member]
Kevin Gopaul [Member]
Anthony Marciano [Member]
Shawn Matthews [Member]
Director [Member]
Consulting and Advisory Arrangements [Member]
Scenario [Axis]
Forecast [Member]
Phantom Share Units (PSUs) [Member]
Consulting Arrangements [Member]
Ferdinand Groenewald [Member]
Groenewald Enterprises LLC [Member]
Consulting Agreement [Member]
Employment Agreement [Member]
Ms Plummer [Member]
Board of Directors Chairman [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Firm ID
Auditor Opinion [Text Block]
Auditor Name
Auditor Location
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
ASSETS
Current assets:
Cash
Accounts receivable
Sales tax receivable
Due from related party
Net investment in leases, short term
Marketable securities
Other assets held for sale –gold
Prepaid expenses and other assets
Total current assets
Non-current assets:
Property and equipment, net
Right-to-use assets, net
Net investment in leases, long term
Intangible assets, net
Goodwill
Total non-current assets
Total assets
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable and accrued expenses, including $66 and $19 to related parties as of December 31, 2025 and 2024, respectively.
Dividends payable
Convertible notes payable
Embedded derivative liability
Lease liability, short term
Total current liabilities
Deferred tax liability
Total liabilities
Commitments and contingencies (Note 10)
Mezzanine equity:
Redeemable Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; (liquidation preference of $105; cumulative dividends payable of $121 and $110 as of December 31, 2025 and 2024, respectively).
Stockholders’ equity (deficit):
Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock and 1 Special Voting Preferred Stock.
Common stock, $0.001 par value, authorized 500,000,000 shares, 49,805,275 and 17,239,096 issued and outstanding as of December 31, 2025 and 2024, respectively.
Additional paid-in-capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ equity (deficit) attributable to Streamex Corp.
Non-controlling interest
Total stockholders’ equity (deficit)
Total liabilities and stockholders’ equity (deficit)
Statement [Table]
Statement [Line Items]
Accounts payable and accrued expenses, related parties
Temporary equity, par value
Temporary equity, stated value
Temporary equity, shares authorized
Temporary equity, shares issued
Temporary equity, shares outstanding
Liquidation preference
Cumulative dividends
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, voting rights
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenue
Operating expenses:
Research and development
General and administrative
Impairment of long term assets
Depreciation and amortization
Total operating expenses
Loss from operations
Other income (expense):
Interest expense, net
Change in fair value of marketable securities
Loss on warrant settlement
Change in fair value of derivative liability
Change in fair value of embedded derivative
Gain on settlement and forgiveness of accounts payable and other liabilities
Other income (expense), net:
Total other income (expense), net
Loss before income taxes
Income taxes (benefit)
Net loss
Non-controlling interest
Net loss attributable to Streamex Corp.
Preferred stock dividend
Preferred stock deemed dividend
Net loss attributed to Streamex Corp. Common Shareholders
Net loss per common share, basic
Net loss per common share, diluted
Weighted average number of common shares outstanding, basic
Weighted average number of common shares outstanding, diluted
Comprehensive (Loss) Income:
Change in foreign currency translation adjustments
Total comprehensive loss
Comprehensive (loss) income attributable to non-controlling interest
Comprehensive (loss) income attributable to Streamex Corp.
Balance
Balance, shares
Reclassification of exchangeable share to permanent equity
Exercise of warrants
Exercise of warrants, shares
Stock based compensation
Stock based compensation, shares
Sale of common stock under at-the- market offering, net of transaction costs
Sale of common stock under-at-the market offering, net of transaction costs, shares
Common stock issued for investment
Common stock issued for investment, shares
Sale of common stock and warrants
Sale of common stock and warrants, shares
Conversion of exchangeable shares into common stock
Conversion of exchangeable shares into common stock, shares
Common stock issued to settle accounts payable
Common stock issued to settle accounts payable, shares
Preferred stock dividend
Common stock cancelled
Common stock cancelled, shares
Other comprehensive income
Net loss
Accretion of deemed preferred stock dividend
Deemed preferred stock dividend
Common stock issued in exchange of note payable and accrued interest
Common stock issued in exchange of note payable and accrued interest, shares
Stock issued as forgiveness of debt
Stock issued as forgiveness of debt, shares
Warrant modifications expense
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net loss to cash used in operating activities:
Amortization of debt discount and issuance costs
Gain on settlement and forgiveness of accounts payable and other liabilities
Non-cash lease expense
Change in fair value of exchangeable shares derivative liability
Change in fair value of convertible debenture embedded derivative
Change in fair value of marketable securities
Fair value of liability warrants reclassified from permanent equity
Stock based compensation expense
Deferred income taxes
Allowance for credit losses on accounts receivable
Impairment of long-term assets
Warrant modification expense
Changes in operating assets and liabilities:
Accounts receivable
Lease receivables
Sales tax receivable
Employee advances
Change in net investment in leases
Prepaid expenses and other assets
Customer deposits
Accounts payable and accrued expenses
Operating lease liabilities
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investment
Purchase of gold held as long-term investment
Business acquisition, net of cash acquired
Net cash used in investing activity
CASH FLOWS FROM FINANCING ACTIVITIES:
Sale of common stock under at-the- market offering, net of transaction costs
Sale of common stock and warrants
Repayment of finance obligation
Proceeds from convertible note payable, net of issuance costs
Cash paid to settle warrants
Proceeds from issuance of related party note payable
Net cash provided by financing activities
Effect of exchange rate change on cash
Net increase in cash
Cash, beginning of the year
Cash, end of the year
Supplemental disclosures of cash flow information:
Cash paid during the year for interest
Cash paid during the year for income taxes
Non cash investing and financing activities:
Recognition of derivative liability as part of business combination
Recognition of assets acquired as part of business combination
Recognition of liabilities assumed as part of business combination
Common stock issued in settlement of accounts payable and accrued expenses
Dividend payable on preferred stock charged to additional paid-in-capital
Financing obligation entered into in exchange for prepaid insurance
Prepaid stock based compensation
Investment in Empress Royalty Corp. acquired through issuance of common stock
Common stock issued in settlement of accrued severance
Series C convertible preferred stock deemed dividend
Common stock issued for conversion of note payable and accrued interest
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS
LIQUIDITY
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Equity [Abstract]
STOCKHOLDER EQUITY
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS
Noncontrolling Interest [Abstract]
NON-CONTROLLING INTEREST
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
BUSINESS ACQUISITION
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS
Investments, Debt and Equity Securities [Abstract]
MARKETABLE SECURITIES
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER ASSET HELD FOR SALE
Debt Disclosure [Abstract]
CONVERTIBLE DEBENTURES
Income Tax Disclosure [Abstract]
INCOME TAXES
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS AND HEDGING ACTIVITIES
Segment Reporting [Abstract]
SEGMENT REPORTING
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation and Principles of Consolidation
Segment Reporting
Use of Estimates
Concentration of Credit Risk
Accounts Receivable and Allowance for Credit Losses
Revenue
Restricted Gold Holdings
Leases (lessee)
Property and Equipment
Business Acquisition
Intangible Assets
Goodwill
Marketable Securities
Warrants
Fair Value Measurements
Derivative Liability
Convertible Debentures
Embedded Derivative Liability — Bifurcated Conversion Option
Stock Based Compensation
Research and Development Costs
Deferred Income Taxes
Income Tax Uncertainties
Foreign Currency Translations and Transactions
Concentration of Assets
Comprehensive Loss
Net Income (loss) Per Common Share
Recently adopted accounting pronouncements
Recently issued accounting pronouncements not yet adopted
SCHEDULE OF USEFUL LIVES OF PROPERTY PLANT AND EQUIPMENT
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE
SCHEDULE OF PROPERTY AND EQUIPMENT
SCHEDULE OF CARRYING AMOUNT OF GOODWILL
SCHEDULE OF INTANGIBLE ASSETS
SCHEDULE OF FUTURE AMORTIZATION EXPENSE OF INTANGIBLE ASSETS
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSE
Restructuring Cost [Table]
Restructuring Cost and Reserve [Line Items]
SCHEDULE OF EXERCISE PRICE OF STOCK OPTIONS
SCHEDULE OF STOCK OPTION ACTIVITY
SCHEDULE OF OPTIONS GRANTED ASSUMPTIONS USING BLACK-SCHOLES OPTION
SCHEDULE OF INFORMATION RELATED TO WARRANTS
SCHEDULE OF WARRANT ACTIVITY
SCHEDULE OF RESTRICTED STOCK ACTIVITY
SCHEDULE OF NON-CONTROLLING INTEREST
SCHEDULE OF CHANGES IN NON-CONTROLLING INTEREST
SCHEDULE OF TANGIBLE AND IDENTIFIABLE INTANGIBLE ASSETS ACQUIRED AND LIABILITIES ASSUMED
SCHEDULE OF UNAUDITED PRO FORMA CONSOLIDATED RESULTS OF REVENUE AND NET LOSS
SUMMARY OF ASSETS MEASURED AT FAIR VALUE ON NONRECURRING BASIS
SUMMARY OF UNOBSERVABLE INPUTS
SUMMARY OF FAIR VALUE MEASUREMENTS DERIVATIVE LIABILITY
SCHEDULE OF UNOBSERVABLE INPUT
SUMMARY OF FAIR VALUE MEASUREMENTS EMBEDDED DERIVATIVE LIABILITY
SUMMARY OF RECURRING FAIR VALUE MEASUREMENTS
SCHEDULE OF COMPOSITION OF INCOME BEFORE INCOME TAXES
SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE
SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION
SCHEDULE OF ANALYSIS OF DEFERRED TAX ASSETS AND LIABILITIES
SCHEDULE OF NET OPERATING LOSS CARRYFORWARDS
SCHEDULE OF DERIVATIVE INSTRUMENTS ON EARNINGS
SCHEDULE OF SEGMENT REPORTING
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Equity method investment, ownership percentage
Working capital deficit
Cash
Net cash operating activities
Net cash investing activities
Net cash financing activities
Underwritten public offering
Marketable securities
Sale of trust assets
Cash payments
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
AccountingPoliciesTable [Table]
Totals
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Deposits
Cash deposits
Allowance for doubtful accounts
Bad debt expenses
Concentration Risk, Percentage
Impairment charges
Accrued liabilities
Unrecognized tax benefits
Assets
Consolidated asset percentage
Intangible Assets, Net (Including Goodwill)
Cash Equivalents, at Carrying Value
Other Receivables
Long-Term Investments
Total
Less accumulated depreciation
Property and equipment, net
Impairment of long lived assets
Depreciation
Goodwill, beginning
Acquisition
Impairment
Foreign currency translation adjustment
Goodwill, ending
Intangible Asset, Finite-Lived [Table]
Finite-Lived Intangible Assets [Line Items]
Total
Foreign currency translation adjustment
Developed technology
Total accumulated amortization
Intangible assets, net
2026
2027
2028
2029
2030
Thereafter
Intangible Asset, Indefinite-Lived [Table]
Indefinite-Lived Intangible Assets [Line Items]
Goodwill impairment
Amortization expenses
Finite lived intangible asset, useful life
Accrued accounting and legal
Accrued consulting
Accrued interest
Accrued research and development expenses
Accrued office and other
Accrued insurance premium financing
Accrued settlement expense
Accrued payroll
Other accrued expenses
Accounts payable and accrued expenses
Total Premium
Paid as down payment
Paid as down payment
Paid as down payment
Accounts Payable, Other
Accounts payable, monthly installments
Annual percentage rate
Prepaid insurance
Loan payable
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Temporary equity, liquidation preference
Preferred stock, shares issued
Preferred stock, shares outstanding
Dividends payable
Dividends payable
Common stock conversion price
Shares issued, price per share
Conversion of stock, shares converted
Shares issued for services
Conversion price
Effective price
Unstayed judgement amount
Common Stock, Shares Authorized
Common Stock, Shares, Issued
Common Stock, Shares, Outstanding
Reverse stock split
Cancelled
Number of shares cancelled
Derivative Liability, Subject to Master Netting Arrangement, before Offset
Exchangeable of common shares outstanding
Warrants to purchase
Warrants to purchase
Purchase price of warrants
Exercise price, warrants
Sale of stock
Exercise price
Principal balance
Accrued interest
Class of warrant or rights granted
Number of shares issued
Proceeds from issuance or sale of equity
Gross Proceeds
transaction cost
Other offering expenses
Number of shares issued for board fees
Finder's fees
Grant date fair value amount
Share based compensation
Issuance cost
Net of fees
Commitment amount
Share issued
Common stock percentage
Line of credit, percentage
Commitment share issued
Fair vale amount
Subscription amount
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price
Number of Options Outstanding
Number of Options Outstanding Weighted Average Remaining Life
Number of Options Outstanding Options Exercisable
Options Outstanding, Exercise Price
Outstanding shares
Weighted Average Exercise Price Outstanding
Weighted-Average Remaining Contractual Term
Outstanding Aggregate Intrinsic Value
Grants
Weighted Average Exercise Price Grants
Outstanding Aggregate Intrinsic Value, Grants
Forfeited/expired
Weighted Average Exercise Price Forfeited/expired
Outstanding Aggregate Intrinsic Value, Forfeited/Expired
Weighted-Average Remaining Contractual Term
Outstanding shares
Weighted Average Exercise Price Outstanding
Outstanding Aggregate Intrinsic Value
Outstanding shares Exercisable
Weighted Average Exercise Price Outstanding
Weighted-Average Remaining Contractual Term
Outstanding Exercisable Aggregate Intrinsic Value
Business Combination [Table]
Business Combination [Line Items]
Derivative liability
Derivative liability, measurement input, expected life
Subsidiary or Equity Method Investee, Sale of Stock [Table]
Subsidiary or Equity Method Investee [Line Items]
Exercise price
Number Outstanding
Expiration date
Outstanding shares
Weighted-Average Exercise Price, beginning
Weighted-Average Remaining Contractual Term, Ending Outstanding
Issued
Weighted-Average Exercise Price Issued
Weighted-Average Remaining Contractual Term, Issued
Exercised
Weighted-Average Exercise Price Exercised
Exercised
Weighted-Average Exercise Price Expired
Repurchased for cash (Fundamental Transaction election)
Weighted-Average Exercise Price Repurchased for cash
Outstanding shares
Weighted-Average Exercise Price ending
Weighted average remaining contractual term, outstanding
Warrants Vested and expected to vest, Shares
Weighted-Average Exercise Price Vested and expected to vest
Weighted-Average Remaining Contractual Term Vested and expected to ves
Warrants Vested and expected to vest, Aggregate Intrinsic Value
Warrants exercisable, shares
Weighted average exercise price, exercisable
Weighted average remaining contractual term, exercisable
Warrants Exercisable, Aggregate Intrinsic Value
Outstanding shares, beginning
Weighted average exercise price, beginning
Forfeited/expired
Forfeited/expired
Weighted average exercise price,forfeited/expired
Outstanding shares, ending
Weighted average exercise price, ending
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Granted
Vested and issued
Forfeited
Vested restricted shares as of December 31, 2024
Vested restricted shares
Unvested restricted shares
Total
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares to be purchased
Shares authorized
Exercise price
Granted shares
Weighted average exercise price
Weighted average remaining contractual term
Share based expenses
Share based expenses
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Warrants outstanding exercise price
Warrant, Exercise Price, Decrease
Modification expense
Shares issued
Warrants to purchase common stock
Shares of its common stock, warrants
Repurchase of warrant
Repurchase of warrant
Stock price
Restricted common stock
Restricted common stock, value
Services, shares
Remaining number of vested, shares
Vesting year
Restricted common stock, value
Vested common stock, value
Services, value
Share-based payment arrangement, noncash expense
Restricted stock, unamortized
Restricted stock, emaining weighted average life
Shares remaining
NoncontrollingInterestTable [Table]
NoncontrollingInterestLineItems [Line Items]
Majority interest
Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Net income (loss)
Average Non-Controlling interest percentage of profit/losses
Net loss attributable to non-controlling interest
Balance
Net income (loss) attributable to non-controlling interest
Balance
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Discounted fee percentage
Revenue share percentage
Cash
Due from related party
Sales tax receivable
Prepaid expenses and other assets
Trade name
Developed technology
Legal and compliance framework
Goodwill
Total assets acquired
Accounts payable and accrued expenses
Deferred tax liability
Total liabilities assumed
Net assets acquired
Revenue
Net loss
Business acquisition, date
Exchangeable shares
Exchangeable shares per purchased share
Number of common stock authorized for issuance
Exchangeable shares issued, value
Acquisition related costs
Number of shares issued, value
Deferred tax liability
Finite lived intangible assets
Royalty rate
Discount rate
Estimated useful lives
Fair value of net assets acquired
Goodwill acquired
Amortization of intangible assets
Income tax benefit
Accrued finders fees
Severance expense
Value of acquisition
Issuance of shares
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Fair value of intangible assets
Goodwill
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
After tax rate of return
Revenue growth rate description
Useful life
Initial recognition (May 28, 2025)
Change in fair value through reclassification
Reclassification to permanent equity
Balance as of December 31, 2025
Derivative liability measurement input
Initial recognition (November 4 , 2025 and December 17, 2025)
Change in fair value
Settlements
Balance as of December 31, 2025
Embedded derivative liabilities – Yorkville Debentures
Investment in Empress Royalty Corp.
Conversion of stock description
Range (Weighted Average)
Fair value exchangeable shares amount
changes in fair value of warrant derivative liabilities
Investment
Issuance of shares acquired
Outstanding percentage
Issuance of restricted shares
Investments
Share price
Fair value of investment
Unrealized loss of investment
OtherAssetHeldForSaleTable [Table]
OtherAssetHeldForSaleLineItems [Line Items]
Aggregate carrying value
Other liabilities
Inventory write-down
Impairment charges
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Face amount
Stated interest rate
Interest rate effective percentage
Interest rate for basic
Principal payment
Obligation to pay
Debt instrument conversion price
Share price
Convertible debentures
Conversion of convertible shares
Debt instrument collateral
Estimated fair value of embedded derivative liabilities
Gain on embedded derivative
Debt instrument fair value
Debt instrument unamortized discount
Interest expense
Debt instrument conversion converted
Amortization of discounts and issuance costs
Debt instrument outstanding principal
Debt instrument periodic payment
Debt instrument accrued interest
Domestic
Foreign
Federal
State
Foreign
Current income tax provision
Federal
State and local
Foreign
Valuation allowance
Net deferred income tax provision (benefit)
Total income tax provision (benefit)
Expected income tax benefit at the U.S. federal statutory tax rate
Expected income tax benefit at the U.S. federal statutory tax rate, percent
State and local taxes, net of federal benefit
Statutory rate on pre-tax book loss, percent
Foreign tax effects
Foreign tax effects, percent
Effects of cross-border tax laws
Effects of cross- border tax laws, percentage
Research and development credits
Foreign tax effects, percent
Changes in valuation allowance
Valuation allowance, percent
Nontaxable or nondeductible Items:
Unrealized change in derivative value
Unrealized change in derivative value, percent
Stock based compensation
Stock compensation, percent
Other
Other, percent
Deferred tax adjustment
Deferred tax adjustment, percent
Effective Tax Rate
Effective Tax Rate
Other, percent
Accruals
Research & Development Costs
Amortization Expense - Patents and Trademarks
Unrealized Gain/Loss From Foreign Currency Exchange
Nonqualified Stock Options
Charitable Contributions
163(j) Interest Expense Limitation
Net Operating Loss Carryforwards
Foreign Net Operating Loss Carryforward
Research & Development Tax Credit
Other Assets
Total Deferred Tax Assets before Valuation Allowance
Valuation Allowance
Total Deferred Tax Assets
Depreciation Expense
Foreign Acquisition of Intangible Assets Step Up
Total deferred tax liabilities
Net Deferred tax asset (liability)
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Subject to Expiration
Unlimited
Total
Deferred tax assets before valuation allowance
Deferred tax asset offset
Deferred tax liabilities
Valuation allowance, deferred tax asset, change in amount
Change in fair value of embedded derivative
Total gain/loss) included in Other income (expense), net
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Revenues
Research and development - stock-based compensation expenses
General and administrative - stock-based compensation expenses
Total operating and segment expense
Interest income (expense)
Change in fair value of equity investment
Gain on settlement and extinguishment of debt
Other income (expense)
Number of reportable segment
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Other liabilities
Due from related parties
Subsequent Event [Table]
Subsequent Event [Line Items]
Gross proceeds from offering
Principal amount
Conversion price
shares issued
Cash payoff amount
Prepayment premium amount
Cash proceeds
Recognized gain sale of gold
Sale of marketable securities
Stock options, granted
Services fees
Aggregate grant date fair value
Option vested
Option granted
Option nonvested
Cash severance
Salary
Vested shares
Fair value
Unvested equity awards cancelled
Salary
Granted shares
Conversion of stock shares converted
Number of shares issued
Number of shares exercised
Stock options, exercise price
Stock options, remaining contractual term
Stock options, grant-date fair value
Sales tax receivable.
Restricted Gold [Member]
Series C 9% Convertible Preferred Stock [Member]
Change in fair value of derivative liability.
GainLossOnSettlementAndForgivenessOfAccountsPayable
Loss on warrant settlement.
Change in fair value of embedded derivative.
Accretion of deemed preferred stock dividend.
Deemed preferred stock dividend.
Warrant modification expense.
Stock issued as forgiveness of debt.
Stock issued as forgiveness of debt, shares.
Common stock cancelled.
Common stock cancelled, shares.
Common stock issued to settle accounts payable.
Common stock issued to settle accounts payable, shares.
Common stock issued for investment.
Common stock issued for investment, shares.
Allowance for credit losses on accounts receivable.
Increase decrease in sales tax receivable.
Increase decrease in change in net investment in leases.
Sale of common stockunder at the market offering net of transaction costs.
Repayment of finance obligation.
Recognition of derivative liability as part of business combination noncash.
Recognition of assets acquired as part of business combination (non-cash).
Recognition of liabilities assumed as part of business combination (non-cash).
Common stock issued in settlement of accounts payable and accrued expenses.
Dividend payable on preferred stock charged to additional paid in capital.
Financing obligation entered into in exchange for prepaid insurance.
Common stock issued in settlement of accrued severance.
Common stock issued for conversion of note payable and accrued interest.
Investment acquired through issuance of common stock.
Prepaid stock based compensation.
Change in fair value of exchangeable shares derivative liability.
Change in fair value of convertible debenture embedded derivative.
Change in fair value of marketable securities.
Fair value of liability warrants reclassified from permanent equity.
Payments for gold held as long term investment.
Viral Clear [Member]
BioSig AI Sciences, Inc. [Member]
Working captal deficit
Accounts Receivable and Allowancef or Credit Losses [Policy Text Block]
Warrants Policy [Policy Text Block]
Deferred Income Taxes [Policy Text Block]
Concentration of Assets [Policy Text Block]
Recently Adopted Accounting Pronouncements [Policy Text Block]
One Customer [Member]
Testing Demo Equipment [Member]
Consolidated asset percentage.
Foreign currency translation adjustment
Compliance Framework [Member]
Accrued consulting current.
Accrued settlement expense.
Accrued office expense and other expense.
Accrued research and development expenses.
Accrued insurance premium financing.
Accrued interest current.
Premium Finance Agreement [Member]
Accounts payable monthly installments.
Annual percentage rate.
2023 Long-Term Incentive Plan [Member]
Class of warrants or right issued.
Class of warrants or right exercised.
Warrants granted weighted average remaining contractual term.
Class of warrant or right exercise price of warrants or rights issued.
Warrants weighted average remaining contractual term issued.
Class of warrant or right exercise price of warrants or rights exercised.
Options Under 9.99 [Member]
Class of warrantsr or right expried.
Options 10.00 To 19.99 [Member]
Class of warrant or right exercise price of warrants or rights expired.
Options 20.00 To 49.99 [Member]
Repurchased for cash fundamental transaction election.
Options 50.00 To 69.99 [Member]
Repurchased for cash.
Class of warrant or rights weighted average exercise price of warrants or rights outstanding.
Warrants outstanding weighted average remaining contractual term.
Class of warrant or rights vested and expected to vest outstanding.
Class of warrant or rights weighted average exercise price of warrants or rights vested and expected to vest outstanding.
Warrants vested and expected to vest outstanding weighted average remaining contractual term.
Class of warrant or rights exercisable.
Class of warrant or rights weighted average exercise price of warrants or rights exercisable.
Warrants exercisable weighted average remaining contractual term.
Consultants [Member]
Other comprehensive income.
Weighted average remaining contractual term options outstanding.
Third Party Consultants and Employees [Member]
Share based compensation arrangement by share based payment award options grants intrinsic value.
Share based compensation arrangement by share based payment award options forfeited expired intrinsic value.
Employees [Member]
Chief Investment Officer [Member]
Share based compensation arrangement by share based payment award options exercisable weighted average remaining contractual term.
Cumulative dividends payable,
Viral Clear Pharmaceuticals Inc [Member]
Effective price.
Unstayed judgement amount.
BioSig AI Sciences, Inc. [Member]
Schedule of Warrants or Rights Shares Authorized Exercise Price Range [Table Text Block]
Stock issued during period shares cancelled
Endicott Management Partners LLC [Member]
Warrants At 0.3000 [Member]
Warrants At 0.9547 [Member]
Warrants At 17800 [Member]
Warrants At 40660 [Member]
Warrants At 44550 [Member]
Warrants At 46626 [Member]
Warrants At 49252 [Member]
Warrants At 49290 [Member]
Warrants At 51358 [Member]
Warrants At 71810 [Member]
Warrants At 75020 [Member]
Warrants At 79630 [Member]
Warrants At 90000 [Member]
Warrants At 95960 [Member]
Warrants At 100992 [Member]
Warrants At 102600 [Member]
Warrants At 104678 [Member]
Warrants At 113000 [Member]
Warrants At 132800 [Member]
Warrants At 480000 [Member]
Warrants At 616000 [Member]
Warrants At 33640 [Member]
Warrants expiration date description.
Purchase Agreement [Member]
Underwriting Agreement [Member]
Share based compensation arrangement by share based payment award equity instruments other than options vested number of shares.
Streamex Exchange Acquisition [Member]
Third Party Consultant [Member]
Share based compensation arrangement by share based payment award equity instruments other than options unvested number of shares.
Share based compensation arrangement by share based payment award equity instruments other than options vested and unvested number of shares.
2019 Long-Term Incentive Plan [Member]
Future Vested [Member]
Key Consultant [Member]
Statement Of Income Location Balance [Axis]
General and Administrative Expenses [Member]
Sales Agreement [Member]
Shares issued for cashless exercise of warrants.
Sharebased compensation arrangement by sharebased payment award options issued weighted average remaining contractual term 2.
Modification expense.
Schedule of NonControlling Interest [Table Text Block]
Net Income (Loss)
Average noncontrolling interest percentage of profit losses.
Discounted fee percentage.
Monetary Metals & Co. [Member]
Revenue share percentage.
Streamex Exchange Corporation [Member]
Share Purchase Agreement [Member]
Business combination recognized identifiable assets acquired and liabilities assumed due from related party
Business combination recognized identifiable assets acquired and liabilities assumed sales tax receivable.
Business combination recognized identifiable assets acquired and liabilities assumed trade name.
Business combination recognized identifiable assets acquired and liabilities assumed developed technology.
Business combination recognized identifiable assets acquired and liabilities assumed legal and compliance framework.
Business combination recognized identifiable assets acquired and liabilities assumed goodwill.
Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accounts payable and accrued expenses.
Royalty rate.
Discount rate.
Blockchain Integration [Member]
Legal and Compliance Frame Work [Member]
Accrued finders fees.
Trade Name [Member]
Relief from Royalty Method [Member]
Royalty Rate [Member]
Revenue growth rate description.
Revenue Growth Rate [Member]
Discount Rate [Member]
Income Tax Rate [Member]
Tax Amortization Period [Member]
Developed Technology [Member]
Multi Period Excess Earnings Method [Member]
Revenue Growth Rates [Member]
Contributory Assets Charge [Member]
Obsolece [Member]
Earnings Before Interest and Taxes [Member]
Cost Approach [Member]
Replacement Cost Growth Rate [Member]
Cap Ex Rates [Member]
After Tax Rate of Return [Member]
Useful Life [Member]
Terminal Growth Rate [Member]
Capitalization Rate [Member]
Expense Rate [Member]
Capital Expenditure Rate [Member]
Fair value exchangeable shares amount.
Permanent equity.
Settlements.
Fair value of derivative liability.
Measurement Input Risky Yield [Member]
Outstanding percentage.
Brinks Bailee Agreement [Member]
Restricted [Member]
Unrestricted [Member]
Debenture Purchase Agreement [Member]
First Closing [Member]
Second Closing [Member]
Research and development stock based compensation expenses.
General and administrative stock based compensation expenses.
Henry McPhie [Member]
Nondeductible expense deferred tax.
Unrealized loss.
Change in derivative value rate.
Deferred tax adjustment rate.
Valuation allowance.
2038 to 2045 [Member]
Deferred tax assets in research development tax credit.
Deferred tax assets in amortization expense patents and trademarks.
Deferred tax assets in unrealized gain loss from foreign currency exchange.
Deferred tax assets in nonqualified stock options.
Deferred tax assets in charitable contributions.
Deferred tax assets in interest expense limitation.
Deferred tax asset offset.
Foreign acquisition of intangible sssets.
Depreciation expense.
Empress Royalty Corp [Member]
Employment Agreement [Member]
Ms Plummer [Member]
Kevin Gopaul [Member]
Anthony Marciano [Member]
Shawn Matthews [Member]
Non Employee Director [Member]
Consulting and Advisory Arrangements [Member]
Groenewald Enterprises LLC [Member]
Consulting Agreement [Member]
Ferdinand Groenewald [Member]
Testing and Demo Equipment [Member]
2026-2031 [Member]
2032-2037 [Member]
Market Offering Agreement [Member]
Securitization Platform [Member]
Schedule of Effect of Significant Unobservable Inputs [Table Text Block]
Convertible Debentures Convertible [Member]
Restricted Stock Awards [Member]
Restricted Stock Units and Restricted Stock Awards [Member]
Consulting Arrangements [Member]
BioSig AI Sciences, Inc. [Member] [Default Label]
Assets, Current
Assets, Noncurrent
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
LossOnWarrantSettlement
ChangeInFairValueOfEmbeddedDerivative
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Dividends, Preferred Stock
Preferred Stock Dividends, Income Statement Impact
Net Income (Loss) Available to Common Stockholders, Basic
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
OtherComprehensiveIncome
Deemed preferred stock dividend
AllowanceForCreditLossesOnAccountsReceivable
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Leasing Receivables
IncreaseDecreaseInSalesTaxReceivable
Increase (Decrease) in Other Receivables
Increase (Decrease) in Prepaid Expense
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Investments
PaymentsForGoldHeldAsLongtermInvestment
Payments to Acquire Businesses, Net of Cash Acquired
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
SaleOfCommonStockUnderAttheMarketOfferingNetOfTransactionCosts
RepaymentOfFinanceObligation
Repayments of Debt
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Revenue from Contract with Customer [Policy Text Block]
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Cash and Cash Equivalent
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Foreign currency translation adjustment [Default Label]
Finite-Lived Intangible Assets, Net
Payments to Acquire Finance Receivables
Dividends Payable
CumulativeDividendsPayable
Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
ClassOfWarrantsOrRightExpried
Class of warrant or rights weighted average exercise price of warrants or rights outstanding
Class of warrant or rights vested and expected to vest outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsVestedAndExpectedToVestOutstanding
Class of warrant or rights exercisable
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumberOfShares
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedNumberOfShares
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnvestedNumberOfShares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price
Stock Repurchased During Period, Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDueFromRelatedParty
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSalesTaxReceivable
Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
Business Combination, Recognized Asset Acquired, Asset
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedExpenses
Business Combination, Recognized Liability Assumed, Deferred Tax Liability
Business Combination, Recognized Liability Assumed, Liability
Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
Business Combination, Pro Forma Information, Pro Forma Revenue
Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax
Deferred Tax Liabilities, Goodwill and Intangible Assets
Goodwill, Fair Value Disclosure
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs
Current Federal, State and Local, Tax Expense (Benefit)
Current Income Tax Expense (Benefit)
Deferred Federal Income Tax Expense (Benefit)
Deferred Foreign Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount
Effective Income Tax Rate Reconciliation, Percent
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Deferred Tax Assets, Valuation Allowance
Deferred Income Tax Assets, Net
DepreciationExpense
Deferred Tax Liabilities, Gross
Deferred Tax Liabilities, Net
Operating Loss Carryforwards
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Other Liabilities, Current
Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold